RECENT NEWS

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of its first laboratory developed test (LDT) FibroSIGHT.

NHS England has announced the incoming team who will help lead the organisation’s transition into the Department of Health and Social Care.

The UK Health Security Agency (UKHSA) has launched genomic surveillance of hepatitis C virus (HCV) in a bid to monitor drug resistance, tackle harder to treat viral strains, and detect outbreaks sooner.

The Medicines and Healthcare products Regulatory Agency (MHRA) welcomed Health Minister Karin Smyth MP to its science campus recently as part of British Science Week to demonstrate how innovations become safe, effective treatments for NHS patients.

The government has revealed more details on how the functions of NHS England will be absorbed into the Department of Health and Social Care (DHSC), saying the move will reduce bureaucracy, make savings and empower NHS staff to deliver better care for patients.

Prime Minister Sir Keir Starmer has announced that NHS England will be abolished to "cut bureaucracy" and bring management of the health service "back into democratic control", in a speech on 13 March about reshaping the state and civil service.

Veterinary microbiologists and pathologists are at the forefront of addressing antimicrobial resistance in animals. A new position statement from The Royal College of Pathologists (RCPath) focuses on a series of recommendations to help tackle this global threat.

NHS England has announced changes to its leadership team, with three leading board members taking the decision to stand down at the end of March, ahead of a restructure which could see the body halve in size.

Dyfed Alsop has been appointed as the new Chief Operating Officer and Deputy Chief Executive Officer of the UK Health Security Agency (UKHSA), starting 1 May 2025.

ARUP Laboratories has expanded its AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides. With this expansion, ARUP Laboratories will become the first and only laboratory to apply AI-augmented screening to the entire ova and parasite testing process.

Liquid biopsy platform firm Tethis and Israel-based Sheba Medical Center have announced a research collaboration to evaluate circulating tumour cells (CTCs) in rectal cancer patients using Tethis' proprietary technology.

Previous IBMS President and Clinical Pathology Lead and Lead Healthcare Scientist Debra Padgett has been awarded an Honorary Fellowship from The Royal College of Pathologists (RCPath) in recognition of her outstanding contributions to pathology and biomedical science.

Medical robotics firm Vitestro has unveiled its autonomous blood drawing device: Aletta, the first autonomous robotic device designed to perform automated blood draws.

Beckman Coulter Life Sciences - in a new partnership with Rarity Bioscience AB - offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research.

In a UK first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they can diagnose bacterial infections faster and more accurately.

Aiforia and Orion, a Finnish pharmaceutical company, have announced the extension of their collaboration to include the use of Aiforia's software solution for preclinical study evaluations.

For the first time, genomic data for over 37,000 children and parents collected over multiple decades from across the UK are now available to researchers worldwide.

Precision cancer diagnostics firm Epredia has announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx digital pathology solution.

The NIHR HealthTech Research Centre in In Vitro Diagnostics (HRC IVD) recently launched, bringing together industry, academia, and the healthcare sector to discuss the Centre’s ambitions and priorities.

The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer at the Medicines and Healthcare products Regulatory Agency (MHRA).